Antioxidant 8-alkylamino-1,4-benzoxazines, (R,S)-(3-tert-butyl-8-phenylethy
lamino-3,4-dihydro-2H-1,4-benzoxazin-5-yl) (phenyl) methanone (S 24429) and
(R,S)-(3-cyclopentyl-8-benzylamino-3,4-dihydro-2H-1,4-benzoxazin-5-yl) (ph
enyl) methanone (S 24718), were prepared according to a two-step one-pot el
ectrochemical procedure. These compounds had been selected from a previous
study of structure/activity. Both compounds (1-100 muM) prevented the fall
in ATP levels caused by 24 h of hypoxia in astrocytes. Both compounds (1 an
d 10 mg/kg i.p.) were powerful neuroprotective agents in protecting against
the lesions induced by 15 mug S-bromo-willardiine injected into the cortex
or white matter of 5-day old mice pups. In contrast, exifone, an antioxida
nt compound, was inactive at these doses. S 24429 and S 24718 appear to be
novel neuroprotective agents, which are effective in a model of brain damag
e mimicking the lesions underlying cerebral palsy. (C) 2001 Elsevier Scienc
e B.V. All rights reserved.